ACT-Together (Acting on Cancer Testing-Together)
To determine the feasibility of a group-based education intervention to improve adherence to recommend surveillance and risk reducing procedures, with a focus at medically underserved women and racial/ethnic minorities with BRCA 1 and 2.
Cancer
OTHER: Education Content|OTHER: Focus Group
Safety and Adverse Events (AEs), Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0, Through study completion; an average of 1 year.
Primary Objective:

To assess the feasibility benchmarks of this intervention by estimating:

1. The enrollment of participants over a 3-month period.
2. Attendance of participants randomized to the ACT-Together Intervention.
3. Completion of baseline and follow up surveys.

Secondary Objectives:

1. Increase breast cancer screening rates or intention to undergo breast cancer screening.
2. Increase uptake of risk-reducing bilateral salpino-oophorectomy (rrBSO) or intention to undergo rrBSO.
3. Demonstrate increase in perceived susceptibility and benefits to risk reducing interventions, and decreased barriers as measured by the Revised Champion Health Belief Scale.

Exploratory Objective:

1. Participant satisfaction with the ACT-Together intervention.